Laprophan Raises $223 Million in Africa's Largest Pharma IPO
· Business · Bloomberg, CNBC
Laprophan, an African pharmaceutical company, successfully raised 2.22 billion dirhams, equivalent to $223 million, through an initial public offering. This IPO was conducted on the Casablanca stock exchange. The flotation marks the largest ever by an African pharmaceutical company.
Why it matters
This IPO sets a new benchmark for pharmaceutical companies in Africa, potentially encouraging more investment and growth in the region's healthcare sector. It demonstrates significant investor confidence in Laprophan and the broader African pharmaceutical market.
Read the original report — Bloomberg
Join us on Telegram
Breaking news the moment it lands. At 10,000 members we ship the Android app.